DIPG

Clinical trials for DIPG explained in plain language.

Never miss a new study

Get alerted when new DIPG trials appear

Sign up with your email to follow new studies for DIPG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Promising combo therapy for childhood cancers enters human trials

Disease control Recruiting now

This study tests a combination of two drugs—Lutathera (a targeted radiation therapy) and olaparib (a PARP inhibitor)—in children and teens aged 3 to 18 with solid tumors that have come back or not responded to standard treatment. The goal is to find the safest dose and see if the…

Matched conditions: DIPG

Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control

Last updated May 17, 2026 04:17 UTC

DIPG

Get alerted when new DIPG trials appear

Promising combo therapy for childhood cancers enters human trials